4//SEC Filing
COHEN RON 4
Accession 0001209191-22-020260
CIK 0001008848other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:26 PM ET
Size
5.1 KB
Accession
0001209191-22-020260
Insider Transaction Report
Form 4
COHEN RON
President and CEO
Transactions
- Sale
Common Stock
2022-03-17$1.70/sh−2,289$3,895→ 129,601 total
Footnotes (2)
- [F1]These sales are primarily intended to cover the tax liability resulting from the settlement of vested restricted stock units.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.70 to $1.74 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001272354
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:26 PM ET
- Size
- 5.1 KB